Otsuka Corporation

4768.T·Tokyo·Technology
Compare
3,775.00+28.00 (+0.75%)today
At close: Nov 5, 3:30 PM JST · May be delayed up to 20 min · JPY

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close3,747.00
Open3,789.00
Day range3,676.003,845.00
52-week range2,697.004,518.00
Off day high−1.82%
Off 52-week high−16.45%
Volume3.92M
Avg. volume (3M)1.53M
Market cap1.43T
EPS (TTM)177.48
Forward P/E24.82
P/E ratio (TTM)21.27
Dividend yield2.67% (100.00)
Beta (5Y)0.10
Shares outstanding379.20M
Short interest—
Earnings dateOct 30, 2026
Analyst target3,889.17
Profit margin4.79%

Against its peers

Compare in full ›
4768.T 9658.T 2327.T 4733.T 2359.T 9746.T
Market cap 1.43T 50.28B 731.19B 786.35B 27.91B 221.25B
P/E (TTM) 21.3 19.0 21.7 39.3 9.4 16.1
Forward P/E 24.8 — 25.5 43.3 — 19.5
Price/book 3.5 1.7 2.6 4.5 1.3 2.0
Dividend yield 2.67% 3.08% 2.22% 1.29% 3.14% 2.56%
1-year change +24.03% +28.00% +6.09% +15.73% −6.96% +6.19%
Today +0.75% +2.99% −0.22% +4.18% +1.67% +5.24%

The closest companies by business and industry (Information Technology Services). Prices may be delayed up to 20 min.

Latest news

All 4768.T news ›
otsuka-us.com·Positive

Otsuka Presents Landmark Final Phase 3 VISIONARY Results at ASN Demonstrating VOYXACT® (sibeprenlimab-szsi) Stabilized Kidney Function and Reduced Risk of Disease Progression and Kidney Failure, Redefining Treatment Paradigm in IgA Nephropathy | Otsuka US

You will now be redirected to www.otsuka-us.com in 20 seconds. Top panel from New England Journal of Medicine, Rizk DV, Barratt J, Suzuki Y, et al, Sibeprenlimab in IgA Nephropathy ─ Final Phase 3 Trial Analysis, Volume No. 396; page…

From the 4Search news index, newest first.

In the news

7mentions in 30 days
7with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance